It is a healthcare private limited company based in Aurangabad, Maharashtra, India, established in 2010.
2010 | Aurangabad, Maharashtra, India | ActiveEmrald Medical Research Private Limited, a active private limited company, was established on 07 April 2010 in Aurangabad, Maharashtra, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U73100MH2010PTC201818. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹17.00 Cr and a paid-up capital of ₹8.75 Cr.
It upholds a compliant status. Its leadership includes Shivaji Pandharinath Jawale (Director), Girish Vallabh Mahale (Director). Past directors included Unmesh Vidyadhar Takalkar, Mandar Suresh Abhyankar. It holds no open charges and ₹87.16 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gurudeo Appt., Flat No-6, Manjeet Nagar, Opp. Akashwani, Jalna Road,, Aurangabad, Maharashtra, 431001.
U73100MH2010PTC201818
201818
07 April 2010
₹17.00 Cr
₹8.75 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Emrald Medical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivaji Pandharinath Jawale | Director | 01 Oct 2024 | Current |
| Girish Vallabh Mahale | Director | 30 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jan 2022 | Past |
| Pramod Abcsdd | Director | 17 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Emrald Medical Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.97% increase. The company also saw a substantial improvement in profitability, with a 42.54% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Emrald Medical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹871,632,442.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 2021 | Others | ₹2.06 Cr | Satisfied |
| 26 Mar 2019 | The Pandharpur Urban Co-Op. Bank Ltd. | ₹40.10 Cr | Satisfied |
| 11 Mar 2019 | Others | ₹45.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Emrald Medical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Emrald Medical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emrald Medical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shivaji Pandharinath Jawale was appointed as a Director was appointed as a Director on 01 Oct 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity Emrald Medical Research Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Progress on Emrald Medical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 11 Mar 2019 via Charge ID 100250871 with Others was fully satisfied on 12 Dec 2022. was completed.
The activity A charge registered on 01 Oct 2021 via Charge ID 100492804 with Others was fully satisfied on 03 Oct 2022. was completed.
A charge registered on 26 Mar 2019 via Charge ID 100252028 with The Pandharpur Urban Co-Op. Bank Ltd. was fully satisfied on 03 Oct 2022. was recorded as a recent event.
The CIN of Emrald Medical Research Private Limited is U73100MH2010PTC201818.
Emrald Medical Research Private Limited is headquartered at Gurudeo Appt., Flat No-6, Manjeet Nagar, Opp. Akashwani, Jalna Road,, Aurangabad, Maharashtra, 431001.
Emrald Medical Research Private Limited was incorporated on 07 April 2010.
The current directors of Emrald Medical Research Private Limited are
The primary industry of Emrald Medical Research Private Limited is Hospital And Medical Care.
Emrald Medical Research Private Limited is unlisted.
The authorized capital of Emrald Medical Research Private Limited is ₹17.00 Cr, and the paid-up capital is ₹8.75 Cr.
The compliance status of Emrald Medical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX